News – Page 130 – Endpoints News

Dupixent wins EU label expansion in COPD ahead of delayed FDA decision

10 months ago

Flagship appears to boost target of eighth fund by up to $500M

10 months ago

Beacon raises $170M to take on J&J in ocular gene therapy

10 months ago

GSK reworks CureVac deal, paying $429M upfront to grab control of mRNA flu and Covid vaccines

10 months ago

Emergent, HHS disclose $250M updated contract that includes anthrax and smallpox vaccines

10 months ago

London court upholds Moderna patent in vaccine dispute with Pfizer, but invalidates another

10 months ago

Updated: Eli Lilly wins long-awaited approval for Alzheimer’s drug

10 months ago

'Optimizing R&D structure is also on the horizon, without exception,' new Sumitomo Pharma CEO says

10 months ago

Nikkei Biotechnology

As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds

10 months ago

Moderna wins $176M BARDA award to finance bird flu work

10 months ago

Yuhan, Ubix ink licensing deal; Xenpozyme's royalty deal

10 months ago

Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot

10 months ago

Checkpoint Therapeutics refiles PD-L1 drug cosibelimab after FDA rejection

10 months ago

J&J and Legend say Carvykti improved survival in earlier-line multiple myeloma

10 months ago

Four key weight loss readouts to watch at #EASD24

10 months ago

Samsung Bio pulls in $1.06B manufacturing deal with unnamed US pharma company

10 months ago

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

10 months ago

FTC investigates Teva over patents, doubling down on 'bogus' Orange Book listings

10 months ago

Seeking 'financial flexibility,' Esperion sells European royalty on cholesterol-lowering drugs

10 months ago

Cassava says two senior employees included in federal probes

10 months ago

Takeda to lay off more employees in Massachusetts

10 months ago

FDA says cancer drug cisplatin is no longer in shortage

10 months ago

Corrected: Boehringer Ingelheim, Gubra put a second candidate into the obesity race

10 months ago

UniQure sells Massachusetts manufacturing site to Genezen as it continues to downsize

10 months ago

First page Previous page 127 128 129130131 132 133 Next page Last page